IPCA LABORATORIES LTD. - Updates on Open Offer to the Shareholder of Krebs Biochemicals & Industries

Krebs Biochemicals & Industries Ltd has submitted to BSE a copy of Recommendation of Committee of Independent Directors (IDC) on the Open Offer to the Equity Shareholders of Krebs Biochemicals and Industries Ltd ("Target Company/TC") by Ipca Laboratories Ltd ("the Acquirer") for acquisition of 35,73,515 Equity Shares under Regulations 3(1) and 4 of SEBI (Substantial Acquisition of Shares and Takeovers) Regulations, 2011 (" SEBI SAST Regulations").